Olaptesed pegol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olaptesed pegol, covering 2025-06-27 to 2025-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer [Phase 2]